Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05853978 · ClinicalTrials.gov registry record · Phase 4
The Evaluation of Balanced Salt Solution During Cataract Surgery
A Phase 4 study of Cataract and Fuchs Dystrophy, sponsored by Adam Fedyk, MD, FACS.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT05853978: Completed Phase 4 study of Cataract and Fuchs Dystrophy, sponsored by Adam Fedyk, MD, FACS.
NCT05853978 is a Phase 4 study of Cataract and Fuchs Dystrophy that has completed, run by Adam Fedyk, MD, FACS. The registered enrollment target is 26 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05853978, a Phase 4 study of Cataract and Fuchs Dystrophy, has completed, sponsored by Adam Fedyk, MD, FACS.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify if the use of BSS PLUS® Sterile Intraocular Irrigating Solution as an irrigation solution leads to improved corneal outcomes vs BSS® Sterile Irrigating Solution in more compromised corneas.
Primary Outcome
Changes in central corneal thickness following cataract surgery with BSS PLUS® Sterile Intraocular Irrigating Solution, as compared to BSS® Sterile Irrigating Solution
Conditions Studied
Interventions
- DRUG BSS Plus
- DRUG BSS
Study Locations (1)
Missouri
- St. Louis Eye Institute - Town and Country
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 4 |
What the finished NCT05853978 record still lists
NCT05853978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which BSS Plus is the first listed.
NCT05853978 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05853978 about?
NCT05853978 is a clinical study titled "The Evaluation of Balanced Salt Solution During Cataract Surgery". This study aims to identify if the use of BSS PLUS® Sterile Intraocular Irrigating Solution as an irrigation solution leads to improved corneal outcomes vs BSS® Sterile Irrigating Solution in more compromised corneas.
What is the current status of trial NCT05853978?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2023-04-17. Estimated completion is 2025-03-31.
What conditions does trial NCT05853978 study?
This clinical trial studies the following conditions: Cataract, Fuchs Dystrophy.
What interventions are being tested in trial NCT05853978?
The interventions under investigation include: BSS Plus (DRUG), BSS (DRUG).
Who is sponsoring clinical trial NCT05853978?
This trial is sponsored by Adam Fedyk, MD, FACS, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05853978 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05853978's enrollment target sits among peer trials
26 76th of 83 higher than 8 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI